Compare Citius Pharmaceuticals Inc (CTXR) vs United States Natural Gas Fund (UNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs United States Natural Gas Fund — how do they compare? Citius Pharmaceuticals Inc trades at $0.54 (market cap $14.64M), while United States Natural Gas Fund trades at $10.48. Which is the better fit depends on your goals.
| CTXR | UNG | |
|---|---|---|
Market Cap | $14.64M | — |
Sector | Health | Commodities - Energy |
52-Week High | $1.82 | $16.90 |
52-Week Low | $0.53 | $10.15 |
Enterprise Value | $10.86M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CTXR trades at $0.54, down 7.33% in the last session, with a bearish technical signal from moving averages. The company reported a net loss of $37.43M for 2025 and has missed earnings expectations for the last three quarters. Recent news highlights progress with LYMPHIR, including Phase 1 data presentations at ASCO and international expansion, alongside $5.6M in net revenue for the first half of 2026.
Despite a high analyst buy consensus (83%), CTXR faces significant fundamental challenges with negative profitability and cash burn. Investment opportunity hinges on successful commercialization of LYMPHIR, but risks include ongoing losses, dilution from recent financing, and clinical execution uncertainties. The stock remains speculative with high risk-reward dynamics.
UNG trades at $10.37, down 2.17% today, with a bearish technical signal from moving averages. The fund tracks natural gas futures, facing headwinds from contango effects and weather-dependent demand. Recent news highlights volatility tied to LNG exports and storage data, with EIA forecasting record 2026 supply and demand (Reuters, 2026-06-09).
Outlook remains cautious due to structural challenges in futures roll costs and price sensitivity to weather. Risks include production swings and geopolitical factors, while opportunities hinge on sustained LNG demand growth. Long-term performance has been hampered by contango, as noted by 24/7 Wall Street (2026-05-28).
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About United States Natural Gas Fund
UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →
